Hepa1-6-hPD-L1
品系基本信息
驗(yàn)證數(shù)據(jù)
1. In vitro?Expression of Hepa1-6-hPDL1 cell line
The hPDL1?protein expression in the Hepa1-6-hPDL1?cells were measured by Flow Cytometry. FACS data showed that significant human PDL1?expression in the Hepa1-6-hPDL1?cell line.
Figure?1. hPDL1 expression in Hepa1-6-hPDL1 cell line
2. Characterization of in vivo?growth kinetics
To test the take rates, and?the tumor growth characteristics of Hepa1-6-hPDL1?cell line, cells?were subcutaneously inoculated into the C57BL/6 mice. The tumor growth curve was?shown in the Fig 2.
Figure?2. Tumor growth curve of Hepa1-6-hPDL1 syngeneic model (n=4)
Figure?3. Body weight change of Hepa1-6-hPDL1 syngeneic model (n=4)
3. Expression of hPDL1 protein in tumors
To verify the hPDL1 protein expression, the tumors were dissected and seperated for single cell suspension. Human PDL1 protein expression can be detected in the humanized modified tumors.
Figure?4. The expression of hPDL1 in humanized modified tumors by FACS
你也可能感興趣
Cre-ERT2在無(wú)Tamoxifen誘導(dǎo)的情況下，在細(xì)胞質(zhì)內(nèi)處于無(wú)活性狀態(tài)；當(dāng)Tamoxifen誘導(dǎo)后，Tamoxifen的代謝產(chǎn)物4-OHT（雌激素類似物）與ERT結(jié)合，可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。
查看常見(jiàn)的基因工程小鼠可以分為兩種命名方式，包括基因定點(diǎn)修飾的小鼠命名，比如：敲除、敲入、點(diǎn)突變等等，和隨機(jī)轉(zhuǎn)基因的小鼠命名。
查看
